Investor List:

Top Diagnostics Seed Investors in London (12)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Diagnostics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Shamik Parekh, Investor at Octopus Ventures
Shamik Parekh
Sweet spot: $4.0M
Range: $1M - $20.0M
Investors in London, Investors in Israel, Investors in Europe, Investors in United Kingdom
Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Consumer Health (Series B), Investors in Diagnostics (Seed), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in DeepTech (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series B), Investors in DeepTech (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in Diagnostics (Series B), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Diagnostics (Series A), Investors in Health & Hospital Services (Seed), Investors in DeepTech (Seed), Investors in AI (Series B), Investors in Health IT (Series A), Investors in Digital Health (Seed), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Seed), Investors in Health IT (Series B), Investors in Health IT (Seed), Investors in Diagnostics (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in AI (Series A), Investors in AI (Series B), Investors in Medical Devices (Series B), Investors in DeepTech (Series B), Investors in AI (Seed), Investors in AI (Series A), Investors in AI (Seed), Investors in Medical Devices (Series A), Investors in Consumer Health (Series B), Investors in Medical Devices (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Digital Health (Series B), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Consumer Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in AI (Series B), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Israel (Other Lists), Investors in Health IT (Seed), Investors in AI (Series A), Investors in AI (Seed), Investors in Diverse Investors (Other Lists), Investors in London (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists)
Photo of Claudio D’Angelo, Managing Director at Spex Capital
Claudio D’Angelo
Spex Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Digital Health (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in London (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A)
Photo of Andrew Noyons, Partner at Hambro Perks
Andrew Noyons
Hambro Perks·Partner
Sweet spot: $7.5M
Range: $5.0M - $10.0M
Investors in London
Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Series B), Investors in FinTech (Pre-seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in FinTech (Series B), Investors in FinTech (Series A), Investors in London (Other Lists), Investors in Medical Devices (Series B), Investors in FinTech (Seed), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in FinTech (Pre-seed), Investors in FinTech (Series B), Investors in FinTech (Series A), Investors in FinTech (Seed)
Photo of Martin Glen, Investor at Parkwalk Advisors
Martin Glen
Sweet spot: $1.6M
Range: $1.3M - $2.0M
Investors in London
Investors in Chemicals (Series B), Investors in Diagnostics (Seed), Investors in Chemicals (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Chemicals (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Chemicals (Series B), Investors in Chemicals (Series A), Investors in Digital Health (Series B), Investors in Chemicals (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in FinTech (Series B), Investors in FinTech (Series A), Investors in Pharmaceuticals (Series B), Investors in FinTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Series B), Investors in London (Other Lists), Investors in Digital Health (Seed), Investors in FinTech (Series B), Investors in Digital Health (Series A), Investors in FinTech (Series A), Investors in FinTech (Seed)
Photo of Francis Pollen, Investor at Spex Capital
Francis Pollen
Spex Capital·Investor
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Photo of Filippo Falaschi, Investor at Spex Capital
Filippo Falaschi
Spex Capital·Investor
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Photo of Alun Williams, Investor at Parkwalk Advisors
Alun Williams
Sweet spot: $1.6M
Range: $1.3M - $2.0M
Investors in London
Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in AI (Series B), Investors in Health & Hospital Services (Series B), Investors in London (Other Lists), Investors in AI (Series A), Investors in Diagnostics (Series B), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in AI (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in FinTech (Series B), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in AI (Series B), Investors in Health & Hospital Services (Series B), Investors in AI (Series A), Investors in FinTech (Series B), Investors in Health & Hospital Services (Series A), Investors in AI (Seed), Investors in Health & Hospital Services (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)
Photo of Neil Cameron, Investor at Parkwalk Advisors
Neil Cameron
Sweet spot: $1.6M
Range: $1.3M - $2.0M
Investors in London
Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Advertising (Series B), Investors in Diagnostics (Series A), Investors in Advertising (Series A), Investors in Advertising (Seed), Investors in MarketingTech (Series B), Investors in EnergyTech (Series B), Investors in MarketingTech (Series A), Investors in Retail (Series B), Investors in MarketingTech (Seed), Investors in EnergyTech (Series A), Investors in Digital Health (Series B), Investors in EnergyTech (Seed), Investors in Retail (Series A), Investors in E-commerce (Series B), Investors in Retail (Seed), Investors in SaaS (Series B), Investors in Health IT (Series B), Investors in E-commerce (Series A), Investors in Digital Health (Series A), Investors in Advertising (Series B), Investors in Digital Health (Seed), Investors in Diagnostics (Series B), Investors in Health IT (Series A), Investors in E-commerce (Seed), Investors in SaaS (Series A), Investors in Health IT (Seed), Investors in MarketingTech (Series B), Investors in Diagnostics (Series A), Investors in SaaS (Seed), Investors in Diagnostics (Seed), Investors in FinTech (Series B), Investors in Advertising (Series A), Investors in Advertising (Seed), Investors in FinTech (Series A), Investors in Retail (Series B), Investors in MarketingTech (Series A), Investors in EnergyTech (Series B), Investors in FinTech (Seed), Investors in MarketingTech (Seed), Investors in Retail (Series A), Investors in E-commerce (Series B), Investors in EnergyTech (Series A), Investors in Retail (Seed), Investors in EnergyTech (Seed), Investors in Digital Health (Series B), Investors in London (Other Lists), Investors in Health IT (Series B), Investors in SaaS (Series B), Investors in E-commerce (Series A), Investors in E-commerce (Seed), Investors in Digital Health (Seed), Investors in FinTech (Series B), Investors in SaaS (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in SaaS (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)
Get new data & insights delivered to your inbox